![Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with DERL2 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.](http://www.bioprodhub.com/system/product_images/ab_products/3/sub_2/10513_233153_1574317.jpg)
Formalin-fixed and paraffin-embedded human hepatocarcinoma reacted with DERL2 Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
![Western blot of DERL2 Antibody in MDA-MB231 cell line lysates (35 ug/lane). DERL2 (arrow) was detected using the purified antibody.](http://www.bioprodhub.com/system/product_images/ab_products/3/sub_2/10514_233152_1719634.jpg)
Western blot of DERL2 Antibody in MDA-MB231 cell line lysates (35 ug/lane). DERL2 (arrow) was detected using the purified antibody.
![DERL2 Antibody FC of MCF-7 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.](http://www.bioprodhub.com/system/product_images/ab_products/3/sub_2/10515_233154_1574318.jpg)
DERL2 Antibody FC of MCF-7 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.